Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Nanomedicine. 2012 Oct 3;9(3):419–427. doi: 10.1016/j.nano.2012.09.003

Figure 2.

Figure 2

TNF-α production in THP1 human macrophage model treated with different concentrations of DMHA, MBA and KAFAK. Positive and negative controls are represented as treatment with PBS and LPS respectively. Bars represent average±SEM (N=4). * denotes statistical significance (p<0.05) between treatment groups and LPS.